Expression of c-kit proto-oncogene in canine mastocytoma: A kinetic study using real-time polymerase chain reaction

Journal of Veterinary Diagnostic Investigation

Volumn 18, Issue 4, 2006, Pages 343-349

  Turin, Lauretta ^a,c   Acocella, Fabio ^b   Stefanello, Damiano ^a   Oseliero, Angelo ^b   Fondrini, Danilo ^b   Brizzola, Stefano ^b   Riva, Federica ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Associazione Oncologi Veterinari   (Italy)

^c Sezione di Microbiologia e Immunologia Veterinaria   (Italy)

Author keywords

C kit; Canine; Mastocytoma; Oncogene; Real time reverse transcription PCR

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 33746835305     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870601800404     Document Type: Article

References (28)

1. Boissan M, Feger F, Guillosson J-J, Arock M: 2000, C-kit and c-kit mutations in mastocytosis and other hematological diseases. J Leukoc Biol 67:135-148.
2. Bostock D: 1973, The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 14:27-41.
3. Brazis P, Queralt M, De Mora F, et al.: 2000, Stem cell factor enhances IgE-mediated histamine and TNF-α release from dispersed canine cutaneous mast cells. Vet Immunol Immunopathol 75:97-108.
4. Cockerell GL, MacCoy DM: 1978, Clinicopathological manifestations of selected neoplasms. Cornell Vet 68(Suppl 7):133-150.
5. Hirota S, Isozaki K, Moryiama Y, et al.: 1998, Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580.
6. Kanakura Y, Ikeda H, Kitayama H, et al.: 1993, Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells. Leuk Lymphoma 10:35-41.
7. Kitayama H, Kanakura Y, Furitsu T, et al.: 1995, Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790-798.
8. Kiupel M, Webster JD, Kaneene JB, et al.: 2004, The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41:371-377.
9. Kubo K, Matsuyama S, Katayama K, et al.: 1998, Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor. J Vet Med Sci 60:1335-1340.
10. Liao AT, Chien MB, Shenoy N, et al.: 2002, Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. Blood 100:585-593.
11. Linnekin D: 1999, Early signaling pathways activated by c-kit in hematopoietic cells. Int J Biochem Cell Biol 31:1053-1074.
12. London CA, Galli SJ, Yuuki T, et al.: 1999, Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol 27:689-697.
13. London CA, Kisseberth WC, Galli SJ, et al.: 1996, Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumors. J Comp Pathol 115:399-414.
14. Ma Y, Longley BJ, Wang X, et al.: 1999, Clustering of activating mutations in c-kit's juxtamembrane coding region in canine mast cell neoplasms. J Invest Dermatol 112:165-170.
15. Morimoto M, Tsujimura T, Kanakura Y, et al.: 1998, Expression of c-kit and stem cell factor mRNA in liver specimens from healthy adult dogs. Am J Vet Res 59:363-366.
16. O'Keefe DA, Couto CG, Burke-Schwartz C, Jacobs RM: 1987, Systemic mastocytosis in 16 dogs. J Vet Intern Med 1:75-80.
17. Patnaik AK, Ehler WJ, MacEwen EG: 1984, Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 21:469-474.
18. Preziosi R, Morini M, Sarli G: 2004, Expression of the kit protein (CD117) in primary cutaneous cell tumors of the dog. J Vet Diagn Invest 16:554-561.
19. Reguera MJ, Ferrer L, Rabanal RM: 2002, Evaluation of an intron deletion in the c-kit gene of canine mast cell tumor. Am J Vet Res 63:1257-1261.
20. Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L: 2000, Canine mast cell tumors express stem cell factor receptor. Am J Dermatopathol 22:49-54.
21. Riva F, Brizzola S, Stefanello D, et al.: 2005, A study of mutations in the c-kit gene of 32 dogs with mastocytoma. J Vet Diagn Invest 17:385-388.
22. Simak R, Capodieci P, Cohen DW, et al.: 2000, Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Histol Histopathol 15:365-374.
23. Takaoka A, Toyota M, Hinoda Y, et al.: 1997, Expression and identification of aberrant c-kit protooncogene transcripts in small cell lung cancer. Cancer Lett 115:257-261.
24. Tsujimura T: 1996, Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells. Pathol Int 46:933-938.
25. Vail DM: 1996, Mast cell tumors. In: Small animal clinical oncology, ed. Withrow SJ, MacEwen EG, 2nd ed., pp. 192-210. WB Saunders Co., Philadelphia, PA.
26. Vandenbark GR, deCastro CM, Taylor H, et al.: 1992, Cloning and structural analysis of the human c-kit gene. Oncogene 7:1259-1266.
27. Wehrle-Haller B, Imhof BA: 2001, Stem cell factor presentation to c-kit. J Biol Chem 276:12667-12674.
28. Yarden Y, Kuang WJ, Yang-Feng T, et al.: 1987, Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351.